Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCarclo Regulatory News (CAR)

Share Price Information for Carclo (CAR)

Share Price is delayed by 15 minutes
Get Live Data
32.80    0.10 (0.31%)
Bid:
32.60
Ask:
33.00
Spread: 0.40 (1.227%)
Market Cap: £24.08m
CAR Live PriceLast checked at - London Stock Exchange

Intraday Carclo Share Chart

AGM Statement

3 Sep 2015 07:00

RNS Number : 9155X
Carclo plc
03 September 2015
 

 

3 September 2015

 

Carclo plc

("Carclo" or the "Group")

 

AGM Statement

The board is pleased to announce that the Group has continued to perform strongly during the second quarter and trading remains in line with its expectations for the year ending 31 March 2016.

Technical Plastics has had a good start to the year. The implementation of our expansion strategy has continued with the new Chinese factory on course to commence manufacturing within the next few weeks. Our successful drive to improve operational efficiency has so far reduced the impact of the weaker Euro, helping to preserve margins in line with the board's expectations.

LED Technologies has been successful in managing the large number of new programmes that it has secured over recent years for new lighting systems from its luxury and supercar customers. Some of these are now transitioning, as expected, to prototyping and production phases. New programme wins have continued in line with our expectations. General lighting product sales have also been strong. As a whole, we currently expect the division to deliver a stronger trading performance for the year than previously anticipated.

Our Precision Engineering Aerospace business has also seen a solid performance in the first half of the financial year. We have recently experienced some weakness in the spares segment order book and, whilst this may recover in the second half, the divisional trading result is expected to be a little behind our previous expectations for the year as a whole.

Carclo Diagnostic Solutions has continued to meet its technical timelines. During the second half of the year it will increase customer and partner interactions and this will assist in providing a validation of the technology prior to moving to further phases of investment.

The Group's financing remains strong and, as expected following the investment in China, Group debt will increase slightly at the half year ending 30 September 2015, before reducing in line with expectations by the end of the financial year.

The board continues to have a strong level of confidence in the future performance of the Group.

- ENDS -

 

Enquiries:

 

Carclo plc

 

01924 268040

Chris Malley, Chief Executive

 

 

Robert Brooksbank, Finance Director

 

 

 

 

 

Peel Hunt LLP

 

0207 418 8900

Justin Jones

 

 

Jock Maxwell Macdonald

 

 

Mike Bell

 

 

 

Weber Shandwick

Nick Oborne

Tom Jenkins

 

020 7067 0000

 

Note to Editors

 

Carclo plc is a public company whose shares are quoted on the London Stock Exchange.

 

Carclo's strategy is to develop and expand its key manufacturing assets where there remain significant further opportunities to drive value. To enhance profit margins and support customers the group has been investing in lower cost regions and new technologies.

 

Approximately three fifths of revenues are derived from the supply of fine tolerance, injection moulded plastic components, mainly for medical products. The balance of revenue is derived mainly from the design and supply of specialised injection moulded LED based lighting systems to the low volume premium automotive industry.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGMSSWFMEFISELU
Date   Source Headline
18th Aug 201111:03 amRNSTR-1: Notification of Major Interest in Shares
12th Aug 20117:00 amRNSInterim Management Statement
29th Jul 20113:12 pmRNSTotal Voting Rights
20th Jul 20112:06 pmRNSPerformance Share Plan
8th Jul 20114:03 pmRNSIssue of Equity
8th Jul 20113:57 pmRNSBlocklisting Interim Review
7th Jul 20112:13 pmRNSHolding(s) in Company
7th Jul 20112:11 pmRNSHolding(s) in Company
29th Jun 20111:50 pmRNSDirector/PDMR Shareholding
7th Jun 20117:00 amRNSFinal Results
7th Apr 20117:00 amRNSPre-close Trading Statement
28th Mar 20112:28 pmRNSHolding(s) in Company
9th Feb 20117:00 amRNSInterim Management Statement
28th Jan 201111:46 amRNSHolding(s) in Company
18th Jan 201111:02 amRNSHolding(s) in Company
17th Jan 20114:06 pmRNSHolding(s) in Company
13th Jan 20114:14 pmRNSHolding(s) in Company
16th Dec 20104:40 pmRNSSecond Price Monitoring Extn
16th Dec 20104:35 pmRNSPrice Monitoring Extension
7th Dec 20103:06 pmRNSDirector/PDMR Shareholding
23rd Nov 20107:00 amRNSHalf Yearly Report
10th Nov 20101:45 pmRNSHolding(s) in Company
8th Nov 20102:12 pmRNSHolding(s) in Company
3rd Nov 20101:58 pmRNSHolding(s) in Company
29th Oct 20104:40 pmRNSSecond Price Monitoring Extn
29th Oct 20104:35 pmRNSPrice Monitoring Extension
29th Oct 201012:07 pmRNSHolding(s) in Company
21st Oct 20104:40 pmRNSSecond Price Monitoring Extn
21st Oct 20104:40 pmRNSSecond Price Monitoring Extn
21st Oct 20104:35 pmRNSPrice Monitoring Extension
21st Oct 20104:35 pmRNSPrice Monitoring Extension
4th Oct 20107:00 amRNSTrading Update
30th Sep 20109:40 amRNSTotal Voting Rights
8th Sep 20107:30 amRNSPerformance Share Plan
3rd Sep 20107:00 amRNSResult of AGM
26th Aug 20104:40 pmRNSSecond Price Monitoring Extn
26th Aug 20104:35 pmRNSPrice Monitoring Extension
18th Aug 20103:26 pmRNSBlock listing application
16th Aug 20107:00 amRNSInterim Management Statement
30th Jul 20108:15 amRNSTotal Voting Rights
30th Jul 20108:00 amRNSIssue of Equity
12th Jul 201011:55 amRNSPerformance Share Plan
12th Jul 201011:45 amRNSHolding(s) in Company
12th Jul 201011:35 amRNSHolding(s) in Company
5th Jul 201011:29 amRNSDirector/PDMR Shareholding
2nd Jul 20103:17 pmRNSTotal Voting Rights
2nd Jul 20103:12 pmRNSHolding(s) in Company
1st Jul 20109:19 amRNSIssue of Equity
25th Jun 201011:45 amRNSHolding(s) in Company
23rd Jun 20103:11 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.